Literature DB >> 32192927

Use of Tisseel, a Fibrin Sealant, for Particulate Graft Stabilization.

Michael S Block1, Michelle Zoccolillo2.   

Abstract

One clinical problem when augmenting a narrow or vertically deficient ridge is maintenance of the graft position during the immediate healing phase and preservation of the augmentation over time. The use of Tisseel (Baxter, Deerfield, IL), a fibrin sealant product, to stabilize particulate grafts, has been reported, and we have reviewed its use. Fibrinogen is converted to fibrin and forms a fibular network that binds the particulate graft. A protease inhibitor is included, which prevents lysis of the coagulum for at least 2 weeks and allows for fibrous ingrowth and graft stabilization. We have reviewed the reported data and included 2 case reports to demonstrate the use of Tisseel.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Year:  2020        PMID: 32192927     DOI: 10.1016/j.joms.2020.02.020

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  2 in total

1.  Safety and Efficacy of Autologous Dermal Fibroblast Injection to Enhance Healing After Full-Thickness Rotator Cuff Repair: First-in-Human Pilot Study.

Authors:  Ji Young Yoon; Joo Hyun Park; Sung-Min Rhee; Hyeon Jang Jeong; Jikhyon Han; Ji-Hye Lee; Saewha Jeon; Joo Han Oh
Journal:  Orthop J Sports Med       Date:  2021-11-10

2.  Use of Photobiomodulation Combined with Fibrin Sealant and Bone Substitute Improving the Bone Repair of Critical Defects.

Authors:  Karina Torres Pomini; Daniela Vieira Buchaim; Ana Carolina Cestari Bighetti; Jesus Carlos Andreo; Marcelie Priscila de Oliveira Rosso; José Stalin Bayas Escudero; Bruna Botteon Della Coletta; Murilo Priori Alcalde; Marco Antonio Hungaro Duarte; Dimitrius Leonardo Pitol; João Paulo Mardegan Issa; Edilson Ervolino; Matheus Bento Medeiros Moscatel; Márcia Zilioli Bellini; Alexandre Teixeira de Souza; Wendel Cleber Soares; Rogerio Leone Buchaim
Journal:  Polymers (Basel)       Date:  2022-10-04       Impact factor: 4.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.